AI & Automation Fuel Global Momentum | StartUp Health Insights: Week of May 13, 2025
From AI-powered drug discovery and clinical data tools to robotic labs and personalized care platforms, health innovation funding and grants this week spanned 20 startups across 7 countries—spotlighting the growing role of automation in diagnostics, care delivery, and drug discovery.
Written by Nicole Kinsey
This week’s reported global health innovation funding included:
PhaseV, a Boston, MA-based AI-enabled clinical development company for life sciences, raised $50M co-led by Accel and Insight Partners, with participation from Viola Ventures, LionBird, and EXOR. <source>
TSOLife, a Tampa, FL-based provider of a resident insight and experience platform for senior living operators, raised $43M led by PeakSpan Capital. <source>
Clarium, a New York, NY-based company providing an AI-powered healthcare supply chain resiliency platform, raised $27M led by Northzone and others. <source>
Inductive Bio, a New York, NY-based technology company using AI for small molecule drug discovery, raised $25M led by Obvious Ventures, with participation from Andreessen Horowitz (a16z) Bio + Health, Lux Capital, S32, Character, and Amino Collective, and angel investors. <source>
Carta Healthcare, a San Francisco, CA-based provider of AI-powered clinical data abstraction, raised $18.25M led by UPMC Enterprises, with participation from MemorialCare Innovation Fund, Rex Health Ventures (the investment fund for the UNC Health), Tampa General Hospital Ventures, Memorial Hermann Health System, Frist Cressey Ventures, Storm Ventures, Paramark Ventures, CU Healthcare Innovation Fund, and Mass General Brigham Ventures. <source>
Complement 1, a New York, NY-based tech startup transforming cancer care through personalized lifestyle medicine, raised $16M led by Owl Ventures and Blume Ventures. <source>
Ethris, a Munich, Germany-based company providing a tech platform to discover, design, and develop innovative therapies, received a €10M ($11.2M) grant from EU4Health. <source>
Olio, an Indianapolis, IN-based care coordination company, raised $11M led by Fulcrum Equity Partners, with participation from Mutual Capital Partners. <source>
Kouper, a New York, NY-based provider of an AI-powered software infrastructure that facilitates the care transition experience for patients, raised $10M from General Catalyst, 25Madison, and CVS Health Ventures. <source>
Alphabiome, a Tel Aviv, Israel-based company developing technology that extracts genetic biomarkers from microbial DNA, raised $8M led by AIX Ventures. <source>
Trilobio, a San Francisco, CA-based company developing an automated robotic lab-in-a-box for biologists, raised $8M led by Initialized Capital, with participation from Argon Ventures and Lowercarbon Capital. <source>
Intrepid Labs, a Toronto, ON, Canada-based biotech company improving drug formulation development through the use of AI and robotics, raised $7M led by AVANT BIO. <source>
CueZen, a Seattle, WA-based developer of an AI-powered personalization engine for health, raised $5M led by Point72 Ventures, with participation from Pack VC, Fortson VC, and Nextinfinity. <source>
PATH EX, a Houston, TX-based medical device company, raised $5M led by IAG Capital Partners, with participation from TMC Venture Fund and Fitz Gate Ventures. <source>
Inbrain Neuroelectronics, a Barcelona, Spain-based clinical-stage neurotechnology company focused on treatments for conditions like Parkinson’s, epilepsy, and stroke rehabilitation, received a €4M ($4.4M) grant from the Spanish Ministry of Industry and Tourism through the PERTE Chip initiative. <source>
Medmain, a Fukuoka, Japan-based medtech startup providing an AI-powered cloud system, raised $3.3M led by One Capital, with participation from Niremia Collective and Plug and Play. <source>
CryoCloud, an Utrecht, the Netherlands-based SaaS biotech startup, raised €2M ($2.2M) led by Nina Capital, with participation from Value Creation Capital, ROM Utrecht, and Utrecht Health Seed Fund. <source>
Pulse Charter Connect, a Chicago, IL-based tech-driven solution to replace the slow, manual coordination that still dominates organ transport, raised $2M co-led by Ivy Ventures and Simplex Ventures, with participation from Cedars Sinai Health Ventures, Belal Badat Ventures, Techstars, and angel investors. <source>
EDGe Surgical, a Chicago, IL-based medical device company, raised $1.3M from undisclosed investors. <source>
Quantix, a Denver, CO-based provider of a healthcare and regulated industry specialist staffing platform, raised an undisclosed amount from Diatonic Healthcare. <source>
Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
Call for Innovation
Are You Ready to Find Your Tribe?
We’re looking for founders and CEOs leading digital health, life science, or biotech companies that want to build a better network to change the world. Health Moonshot Communities are exclusive, mission-aligned networks of founders, CEOs, and partners collaborating to solve the biggest health challenges of our time.
Our communities include: Alzheimer’s Disease, Cardiometabolic Health, Food as Medicine, Mental & Behavorial Health, Type 1 Diabetes, and more.
If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today.
Follow us on LinkedIn for daily updates on Health Transformers.
